You have 9 free searches left this month | for more free features.

City

Edmonton (1)

Toronto (1)

Vancouver (1)

Condition

Autoimmune Diseases (2)

Diabetes Mellitus (2)

Diabetes Mellitus, Type 1 (2)

Endocrine System Diseases (2)

Glucose Metabolism Disorders (2)

Immune System Diseases (2)

Metabolic Disease (2)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

CRISPR Therapeutics AG (2)

Collaborator

ViaCyte (2)

Intervention

vctx210a unit (1)

vctx211 (1)

Study Documents

Intervention Type

combination product (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

VCTX

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial (VCTX211)

Not yet recruiting

Diabetes Mellitus
+6 more

VCTX211

(no location specified)

Sep 30, 2022

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Edmonton, Vancouver, Toronto (VCTX210A unit)

Recruiting

Diabetes Mellitus
+6 more

VCTX210A unit

Edmonton, Alberta, Canada
+2 more

Apr 1, 2022